SWX:NOVNPharmaceuticals
Is It Too Late To Consider Novartis (SWX:NOVN) After Its Strong Five Year Run?
If you are wondering whether Novartis at around CHF123 per share still offers value, the key is to look past the headline price and focus on what you are actually getting for each franc invested.
The stock has returned 1.9% over the last week, is roughly flat over 30 days, and has delivered 13.5% year to date alongside 43.2% over 1 year, 65.7% over 3 years, and 96.0% over 5 years. This naturally raises questions about how much of the story is already reflected in the price.
Recent attention...